166 related articles for article (PubMed ID: 38599652)
1. Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden.
Stamatis P; Mohammad MA; Gisslander K; Merkel PA; Englund M; Turesson C; Erlinge D; Mohammad AJ
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599652
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.
Amiri N; De Vera M; Choi HK; Sayre EC; Avina-Zubieta JA
Rheumatology (Oxford); 2016 Jan; 55(1):33-40. PubMed ID: 26248811
[TBL] [Abstract][Full Text] [Related]
3. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.
Tomasson G; Peloquin C; Mohammad A; Love TJ; Zhang Y; Choi HK; Merkel PA
Ann Intern Med; 2014 Jan; 160(2):73-80. PubMed ID: 24592492
[TBL] [Abstract][Full Text] [Related]
4. Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.
Stamatis P; Turkiewicz A; Englund M; Jönsson G; Nilsson JÅ; Turesson C; Mohammad AJ
J Rheumatol; 2021 Feb; 48(2):251-257. PubMed ID: 32414956
[TBL] [Abstract][Full Text] [Related]
5. Myocardial infarction during giant cell arteritis: A cohort study.
Greigert H; Zeller M; Putot A; Steinmetz E; Terriat B; Maza M; Falvo N; Muller G; Arnould L; Creuzot-Garcher C; Ramon A; Martin L; Tarris G; Ponnelle T; Audia S; Bonnotte B; Cottin Y; Samson M
Eur J Intern Med; 2021 Jul; 89():30-38. PubMed ID: 33610415
[TBL] [Abstract][Full Text] [Related]
6. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
7. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
Mohammad AJ; Nilsson JÅ; Jacobsson LT; Merkel PA; Turesson C
Ann Rheum Dis; 2015 Jun; 74(6):993-7. PubMed ID: 24442881
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in Giant Cell Arteritis: A Population-based Cohort Study.
Stamatis P; Turesson C; Willim M; Nilsson JÅ; Englund M; Mohammad AJ
J Rheumatol; 2020 Mar; 47(3):400-406. PubMed ID: 31154410
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate.
Stamatis P; Turkiewicz A; Englund M; Turesson C; Mohammad AJ
Rheumatology (Oxford); 2021 Dec; 61(1):146-153. PubMed ID: 33742665
[TBL] [Abstract][Full Text] [Related]
10. The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.
Aviña-Zubieta JA; Bhole VM; Amiri N; Sayre EC; Choi HK
Ann Rheum Dis; 2016 Jan; 75(1):148-54. PubMed ID: 25265937
[TBL] [Abstract][Full Text] [Related]
11. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
12. Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.
Saleh M; Turesson C; Englund M; Merkel PA; Mohammad AJ
J Rheumatol; 2016 Aug; 43(8):1559-65. PubMed ID: 27252424
[TBL] [Abstract][Full Text] [Related]
13. Large vessel involvement in biopsy-proven giant cell arteritis: incidence, distribution, and predictors.
Naderi N; Mohammad AJ; Turesson C
Scand J Rheumatol; 2017 May; 46(3):215-221. PubMed ID: 27385090
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years.
Elfishawi MM; Kaymakci MS; J Achenbach S; S Crowson C; Kermani TA; M Weyand C; J Koster M; Warrington KJ
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38331471
[TBL] [Abstract][Full Text] [Related]
16. The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients.
Chung SH; Morcos MB; Pollock PS; Ng B
Clin Rheumatol; 2021 Jul; 40(7):2829-2833. PubMed ID: 33417014
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study.
Turkiewicz A; Stamatis P; Mohammad AJ
RMD Open; 2020 Aug; 6(2):. PubMed ID: 32792416
[TBL] [Abstract][Full Text] [Related]
18. Trajectory of Healthcare Resource Utilization in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Turkiewicz A; Stamatis P; Turesson C; Englund M; Kiadaliri A
J Rheumatol; 2021 Aug; 48(8):1307-1313. PubMed ID: 33649063
[TBL] [Abstract][Full Text] [Related]
19. Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.
Unizony S; Menendez ME; Rastalsky N; Stone JH
Rheumatology (Oxford); 2015 Aug; 54(8):1360-8. PubMed ID: 25667435
[TBL] [Abstract][Full Text] [Related]
20. A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis.
Therkildsen P; de Thurah A; Faurschou M; Baslund B; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
Semin Arthritis Rheum; 2022 Oct; 56():152071. PubMed ID: 35878473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
